[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Insulin Dosing Device Market, Global Outlook and Forecast 2022-2028

April 2022 | 110 pages | ID: I8958E290AB3EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Insulin Dosing Device in global, including the following market information:

Global Insulin Dosing Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Insulin Dosing Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Insulin Dosing Device companies in 2021 (%)

The global Insulin Dosing Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Insulin Dosing Device include Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Copernicus, Dance Biopharm and Debiotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insulin Dosing Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Insulin Dosing Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Dosing Device Market Segment Percentages, by Type, 2021 (%)
  • Insulin Pens
  • Insulin Pumps
  • Insulin Syringes
  • Others
Global Insulin Dosing Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Dosing Device Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Clinic
  • Home Care
  • Others
Global Insulin Dosing Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Dosing Device Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Insulin Dosing Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Insulin Dosing Device revenues share in global market, 2021 (%)

Key companies Insulin Dosing Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Insulin Dosing Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Novo Nordisk
  • Sanofi
  • BD
  • Eli Lilly
  • Medtronic
  • Beta Bionics
  • Copernicus
  • Dance Biopharm
  • Debiotech
  • Insulet
  • MannKind
  • Owen Mumford
  • Roche
  • SOOIL
  • Tandem Diabetes Care
  • Valeritas
  • West Pharma
  • Ypsomed
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Insulin Dosing Device Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Insulin Dosing Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INSULIN DOSING DEVICE OVERALL MARKET SIZE

2.1 Global Insulin Dosing Device Market Size: 2021 VS 2028
2.2 Global Insulin Dosing Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Insulin Dosing Device Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Insulin Dosing Device Players in Global Market
3.2 Top Global Insulin Dosing Device Companies Ranked by Revenue
3.3 Global Insulin Dosing Device Revenue by Companies
3.4 Global Insulin Dosing Device Sales by Companies
3.5 Global Insulin Dosing Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Insulin Dosing Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Insulin Dosing Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Dosing Device Players in Global Market
  3.8.1 List of Global Tier 1 Insulin Dosing Device Companies
  3.8.2 List of Global Tier 2 and Tier 3 Insulin Dosing Device Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Insulin Dosing Device Market Size Markets, 2021 & 2028
  4.1.2 Insulin Pens
  4.1.3 Insulin Pumps
  4.1.4 Insulin Syringes
  4.1.5 Others
4.2 By Type - Global Insulin Dosing Device Revenue & Forecasts
  4.2.1 By Type - Global Insulin Dosing Device Revenue, 2017-2022
  4.2.2 By Type - Global Insulin Dosing Device Revenue, 2023-2028
  4.2.3 By Type - Global Insulin Dosing Device Revenue Market Share, 2017-2028
4.3 By Type - Global Insulin Dosing Device Sales & Forecasts
  4.3.1 By Type - Global Insulin Dosing Device Sales, 2017-2022
  4.3.2 By Type - Global Insulin Dosing Device Sales, 2023-2028
  4.3.3 By Type - Global Insulin Dosing Device Sales Market Share, 2017-2028
4.4 By Type - Global Insulin Dosing Device Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Insulin Dosing Device Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Home Care
  5.1.5 Others
5.2 By Application - Global Insulin Dosing Device Revenue & Forecasts
  5.2.1 By Application - Global Insulin Dosing Device Revenue, 2017-2022
  5.2.2 By Application - Global Insulin Dosing Device Revenue, 2023-2028
  5.2.3 By Application - Global Insulin Dosing Device Revenue Market Share, 2017-2028
5.3 By Application - Global Insulin Dosing Device Sales & Forecasts
  5.3.1 By Application - Global Insulin Dosing Device Sales, 2017-2022
  5.3.2 By Application - Global Insulin Dosing Device Sales, 2023-2028
  5.3.3 By Application - Global Insulin Dosing Device Sales Market Share, 2017-2028
5.4 By Application - Global Insulin Dosing Device Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Insulin Dosing Device Market Size, 2021 & 2028
6.2 By Region - Global Insulin Dosing Device Revenue & Forecasts
  6.2.1 By Region - Global Insulin Dosing Device Revenue, 2017-2022
  6.2.2 By Region - Global Insulin Dosing Device Revenue, 2023-2028
  6.2.3 By Region - Global Insulin Dosing Device Revenue Market Share, 2017-2028
6.3 By Region - Global Insulin Dosing Device Sales & Forecasts
  6.3.1 By Region - Global Insulin Dosing Device Sales, 2017-2022
  6.3.2 By Region - Global Insulin Dosing Device Sales, 2023-2028
  6.3.3 By Region - Global Insulin Dosing Device Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Insulin Dosing Device Revenue, 2017-2028
  6.4.2 By Country - North America Insulin Dosing Device Sales, 2017-2028
  6.4.3 US Insulin Dosing Device Market Size, 2017-2028
  6.4.4 Canada Insulin Dosing Device Market Size, 2017-2028
  6.4.5 Mexico Insulin Dosing Device Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Insulin Dosing Device Revenue, 2017-2028
  6.5.2 By Country - Europe Insulin Dosing Device Sales, 2017-2028
  6.5.3 Germany Insulin Dosing Device Market Size, 2017-2028
  6.5.4 France Insulin Dosing Device Market Size, 2017-2028
  6.5.5 U.K. Insulin Dosing Device Market Size, 2017-2028
  6.5.6 Italy Insulin Dosing Device Market Size, 2017-2028
  6.5.7 Russia Insulin Dosing Device Market Size, 2017-2028
  6.5.8 Nordic Countries Insulin Dosing Device Market Size, 2017-2028
  6.5.9 Benelux Insulin Dosing Device Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Insulin Dosing Device Revenue, 2017-2028
  6.6.2 By Region - Asia Insulin Dosing Device Sales, 2017-2028
  6.6.3 China Insulin Dosing Device Market Size, 2017-2028
  6.6.4 Japan Insulin Dosing Device Market Size, 2017-2028
  6.6.5 South Korea Insulin Dosing Device Market Size, 2017-2028
  6.6.6 Southeast Asia Insulin Dosing Device Market Size, 2017-2028
  6.6.7 India Insulin Dosing Device Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Insulin Dosing Device Revenue, 2017-2028
  6.7.2 By Country - South America Insulin Dosing Device Sales, 2017-2028
  6.7.3 Brazil Insulin Dosing Device Market Size, 2017-2028
  6.7.4 Argentina Insulin Dosing Device Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Insulin Dosing Device Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Insulin Dosing Device Sales, 2017-2028
  6.8.3 Turkey Insulin Dosing Device Market Size, 2017-2028
  6.8.4 Israel Insulin Dosing Device Market Size, 2017-2028
  6.8.5 Saudi Arabia Insulin Dosing Device Market Size, 2017-2028
  6.8.6 UAE Insulin Dosing Device Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novo Nordisk
  7.1.1 Novo Nordisk Corporate Summary
  7.1.2 Novo Nordisk Business Overview
  7.1.3 Novo Nordisk Insulin Dosing Device Major Product Offerings
  7.1.4 Novo Nordisk Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.1.5 Novo Nordisk Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Insulin Dosing Device Major Product Offerings
  7.2.4 Sanofi Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi Key News
7.3 BD
  7.3.1 BD Corporate Summary
  7.3.2 BD Business Overview
  7.3.3 BD Insulin Dosing Device Major Product Offerings
  7.3.4 BD Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.3.5 BD Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Insulin Dosing Device Major Product Offerings
  7.4.4 Eli Lilly Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Medtronic
  7.5.1 Medtronic Corporate Summary
  7.5.2 Medtronic Business Overview
  7.5.3 Medtronic Insulin Dosing Device Major Product Offerings
  7.5.4 Medtronic Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.5.5 Medtronic Key News
7.6 Beta Bionics
  7.6.1 Beta Bionics Corporate Summary
  7.6.2 Beta Bionics Business Overview
  7.6.3 Beta Bionics Insulin Dosing Device Major Product Offerings
  7.6.4 Beta Bionics Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.6.5 Beta Bionics Key News
7.7 Copernicus
  7.7.1 Copernicus Corporate Summary
  7.7.2 Copernicus Business Overview
  7.7.3 Copernicus Insulin Dosing Device Major Product Offerings
  7.7.4 Copernicus Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.7.5 Copernicus Key News
7.8 Dance Biopharm
  7.8.1 Dance Biopharm Corporate Summary
  7.8.2 Dance Biopharm Business Overview
  7.8.3 Dance Biopharm Insulin Dosing Device Major Product Offerings
  7.8.4 Dance Biopharm Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.8.5 Dance Biopharm Key News
7.9 Debiotech
  7.9.1 Debiotech Corporate Summary
  7.9.2 Debiotech Business Overview
  7.9.3 Debiotech Insulin Dosing Device Major Product Offerings
  7.9.4 Debiotech Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.9.5 Debiotech Key News
7.10 Insulet
  7.10.1 Insulet Corporate Summary
  7.10.2 Insulet Business Overview
  7.10.3 Insulet Insulin Dosing Device Major Product Offerings
  7.10.4 Insulet Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.10.5 Insulet Key News
7.11 MannKind
  7.11.1 MannKind Corporate Summary
  7.11.2 MannKind Insulin Dosing Device Business Overview
  7.11.3 MannKind Insulin Dosing Device Major Product Offerings
  7.11.4 MannKind Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.11.5 MannKind Key News
7.12 Owen Mumford
  7.12.1 Owen Mumford Corporate Summary
  7.12.2 Owen Mumford Insulin Dosing Device Business Overview
  7.12.3 Owen Mumford Insulin Dosing Device Major Product Offerings
  7.12.4 Owen Mumford Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.12.5 Owen Mumford Key News
7.13 Roche
  7.13.1 Roche Corporate Summary
  7.13.2 Roche Insulin Dosing Device Business Overview
  7.13.3 Roche Insulin Dosing Device Major Product Offerings
  7.13.4 Roche Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.13.5 Roche Key News
7.14 SOOIL
  7.14.1 SOOIL Corporate Summary
  7.14.2 SOOIL Business Overview
  7.14.3 SOOIL Insulin Dosing Device Major Product Offerings
  7.14.4 SOOIL Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.14.5 SOOIL Key News
7.15 Tandem Diabetes Care
  7.15.1 Tandem Diabetes Care Corporate Summary
  7.15.2 Tandem Diabetes Care Business Overview
  7.15.3 Tandem Diabetes Care Insulin Dosing Device Major Product Offerings
  7.15.4 Tandem Diabetes Care Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.15.5 Tandem Diabetes Care Key News
7.16 Valeritas
  7.16.1 Valeritas Corporate Summary
  7.16.2 Valeritas Business Overview
  7.16.3 Valeritas Insulin Dosing Device Major Product Offerings
  7.16.4 Valeritas Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.16.5 Valeritas Key News
7.17 West Pharma
  7.17.1 West Pharma Corporate Summary
  7.17.2 West Pharma Business Overview
  7.17.3 West Pharma Insulin Dosing Device Major Product Offerings
  7.17.4 West Pharma Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.17.5 West Pharma Key News
7.18 Ypsomed
  7.18.1 Ypsomed Corporate Summary
  7.18.2 Ypsomed Business Overview
  7.18.3 Ypsomed Insulin Dosing Device Major Product Offerings
  7.18.4 Ypsomed Insulin Dosing Device Sales and Revenue in Global (2017-2022)
  7.18.5 Ypsomed Key News

8 GLOBAL INSULIN DOSING DEVICE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Insulin Dosing Device Production Capacity, 2017-2028
8.2 Insulin Dosing Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Dosing Device Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 INSULIN DOSING DEVICE SUPPLY CHAIN ANALYSIS

10.1 Insulin Dosing Device Industry Value Chain
10.2 Insulin Dosing Device Upstream Market
10.3 Insulin Dosing Device Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Insulin Dosing Device Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Insulin Dosing Device in Global Market
Table 2. Top Insulin Dosing Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Insulin Dosing Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Insulin Dosing Device Revenue Share by Companies, 2017-2022
Table 5. Global Insulin Dosing Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Insulin Dosing Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Insulin Dosing Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Insulin Dosing Device Product Type
Table 9. List of Global Tier 1 Insulin Dosing Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin Dosing Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Insulin Dosing Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Insulin Dosing Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Insulin Dosing Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Insulin Dosing Device Sales (K Units), 2017-2022
Table 15. By Type - Global Insulin Dosing Device Sales (K Units), 2023-2028
Table 16. By Application – Global Insulin Dosing Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Insulin Dosing Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Insulin Dosing Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Insulin Dosing Device Sales (K Units), 2017-2022
Table 20. By Application - Global Insulin Dosing Device Sales (K Units), 2023-2028
Table 21. By Region – Global Insulin Dosing Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Insulin Dosing Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Insulin Dosing Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Insulin Dosing Device Sales (K Units), 2017-2022
Table 25. By Region - Global Insulin Dosing Device Sales (K Units), 2023-2028
Table 26. By Country - North America Insulin Dosing Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Insulin Dosing Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Insulin Dosing Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Insulin Dosing Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Insulin Dosing Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Insulin Dosing Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Insulin Dosing Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Insulin Dosing Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Insulin Dosing Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Insulin Dosing Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Insulin Dosing Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Insulin Dosing Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Insulin Dosing Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Insulin Dosing Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Insulin Dosing Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Insulin Dosing Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Insulin Dosing Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Insulin Dosing Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Insulin Dosing Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Insulin Dosing Device Sales, (K Units), 2023-2028
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Insulin Dosing Device Product Offerings
Table 48. Novo Nordisk Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Insulin Dosing Device Product Offerings
Table 51. Sanofi Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BD Corporate Summary
Table 53. BD Insulin Dosing Device Product Offerings
Table 54. BD Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Eli Lilly Corporate Summary
Table 56. Eli Lilly Insulin Dosing Device Product Offerings
Table 57. Eli Lilly Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Medtronic Corporate Summary
Table 59. Medtronic Insulin Dosing Device Product Offerings
Table 60. Medtronic Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Beta Bionics Corporate Summary
Table 62. Beta Bionics Insulin Dosing Device Product Offerings
Table 63. Beta Bionics Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Copernicus Corporate Summary
Table 65. Copernicus Insulin Dosing Device Product Offerings
Table 66. Copernicus Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Dance Biopharm Corporate Summary
Table 68. Dance Biopharm Insulin Dosing Device Product Offerings
Table 69. Dance Biopharm Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Debiotech Corporate Summary
Table 71. Debiotech Insulin Dosing Device Product Offerings
Table 72. Debiotech Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Insulet Corporate Summary
Table 74. Insulet Insulin Dosing Device Product Offerings
Table 75. Insulet Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. MannKind Corporate Summary
Table 77. MannKind Insulin Dosing Device Product Offerings
Table 78. MannKind Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Owen Mumford Corporate Summary
Table 80. Owen Mumford Insulin Dosing Device Product Offerings
Table 81. Owen Mumford Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Roche Corporate Summary
Table 83. Roche Insulin Dosing Device Product Offerings
Table 84. Roche Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. SOOIL Corporate Summary
Table 86. SOOIL Insulin Dosing Device Product Offerings
Table 87. SOOIL Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Tandem Diabetes Care Corporate Summary
Table 89. Tandem Diabetes Care Insulin Dosing Device Product Offerings
Table 90. Tandem Diabetes Care Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Valeritas Corporate Summary
Table 92. Valeritas Insulin Dosing Device Product Offerings
Table 93. Valeritas Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. West Pharma Corporate Summary
Table 95. West Pharma Insulin Dosing Device Product Offerings
Table 96. West Pharma Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Ypsomed Corporate Summary
Table 98. Ypsomed Insulin Dosing Device Product Offerings
Table 99. Ypsomed Insulin Dosing Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Insulin Dosing Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 101. Global Insulin Dosing Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Insulin Dosing Device Production by Region, 2017-2022 (K Units)
Table 103. Global Insulin Dosing Device Production by Region, 2023-2028 (K Units)
Table 104. Insulin Dosing Device Market Opportunities & Trends in Global Market
Table 105. Insulin Dosing Device Market Drivers in Global Market
Table 106. Insulin Dosing Device Market Restraints in Global Market
Table 107. Insulin Dosing Device Raw Materials
Table 108. Insulin Dosing Device Raw Materials Suppliers in Global Market
Table 109. Typical Insulin Dosing Device Downstream
Table 110. Insulin Dosing Device Downstream Clients in Global Market
Table 111. Insulin Dosing Device Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Insulin Dosing Device Segment by Type
Figure 2. Insulin Dosing Device Segment by Application
Figure 3. Global Insulin Dosing Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insulin Dosing Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insulin Dosing Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Insulin Dosing Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Insulin Dosing Device Revenue in 2021
Figure 9. By Type - Global Insulin Dosing Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Insulin Dosing Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Insulin Dosing Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Insulin Dosing Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Insulin Dosing Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Insulin Dosing Device Sales Market Share, 2017-2028
Figure 19. US Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Insulin Dosing Device Sales Market Share, 2017-2028
Figure 24. Germany Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Insulin Dosing Device Sales Market Share, 2017-2028
Figure 33. China Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Insulin Dosing Device Sales Market Share, 2017-2028
Figure 40. Brazil Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Insulin Dosing Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Insulin Dosing Device Sales Market Share, 2017-2028
Figure 44. Turkey Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Insulin Dosing Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Insulin Dosing Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Insulin Dosing Device by Region, 2021 VS 2028
Figure 50. Insulin Dosing Device Industry Value Chain
Figure 51. Marketing Channels


More Publications